Shareholders Equity: The sum of preferred and common equity items.
Dr. Reddy's Laboratories Ltd (RDY) had Shareholders Equity of $4.30B for the most recently reported fiscal year, ending 2026-03-31.
| Income Statement Financials | |
$3.80B |
|
$484.20M |
|
$1.79B |
|
$2.00B |
|
$3.22B |
|
$571.23M |
|
$48.21M |
|
$619.43M |
|
$619.43M |
|
$479.87M |
|
$479.87M |
|
$479.87M |
|
$479.87M |
|
$571.23M |
|
$804.06M |
|
832.36M |
|
833.33M |
|
$0.58 |
|
$0.58 |
|
| Balance Sheet Financials | |
$3.41B |
|
$1.31B |
|
$3.13B |
|
$6.55B |
|
$1.89B |
|
$137.89M |
|
$353.95M |
|
$2.25B |
|
$4.30B |
|
$2.97B |
|
|
Shareholders Equity |
$4.30B |
-- |
|
| Cash Flow Statement Financials | |
$641.33M |
|
$-740.30M |
|
$93.68M |
|
$164.90M |
|
$173.66M |
|
$8.76M |
|
$3.68M |
|
$-75.25M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|